An open label prospective study investigating the effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 15 Jul 2015
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 15 Jul 2015 New trial record